Table 2.
Comparison between all cases | ||||
---|---|---|---|---|
Assay | Region | Suicide Completion | Nonsuicide | P value |
[3H]AF-DX 384 bindinga | BA 24 | 53.5±5.80 | 70.4±2.80 | P<.01 |
BA 46 | 52.5±5.50 | 66.3±2.30 | P=.01 | |
CHRM2 proteinb | BA 24 | 0.52±0.08 | 0.83±0.09 | P=.02 |
BA 46 | 0.51±0.08 | 0.45±0.04 | P=.49 | |
[35S]GTPγS bindinga | BA 24 | 18.5±4.60 | 29.3±4.00 | P=.10 |
BA 46 | 19.8±4.80 | 24.8±4.20 | P=.46 | |
Comparison between mood disorder cases | ||||
[3H]AF-DX 384 bindinga | BA 24 | 53.5±5.80 | 57.4±4.00 | P=.61 |
BA 46 | 52.5±5.50 | 61.1±4.70 | P=.27 | |
CHRM2 proteinb | BA 24 | 0.52±0.08 | 0.67±0.13 | P=.31 |
BA 46 | 0.51±0.08 | 0.50±0.06 | P=.91 | |
[35S]GTPγS bindinga | BA 24 | 18.5±4.60 | 19.3±5.10 | P=.91 |
BA 46 | 19.8±4.80 | 23.3±5.90 | P=.64 |
Abbreviations: BA, Brodmann’s area; CHRM2, muscarinic M2 receptor.
afmol / mg estimated tissue equivalents.
bratio of internal control.